全文获取类型
收费全文 | 1030篇 |
免费 | 66篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 19篇 |
妇产科学 | 9篇 |
基础医学 | 121篇 |
口腔科学 | 120篇 |
临床医学 | 64篇 |
内科学 | 295篇 |
皮肤病学 | 18篇 |
神经病学 | 98篇 |
特种医学 | 8篇 |
外科学 | 133篇 |
综合类 | 2篇 |
一般理论 | 1篇 |
预防医学 | 141篇 |
眼科学 | 7篇 |
药学 | 32篇 |
中国医学 | 8篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 13篇 |
2022年 | 20篇 |
2021年 | 28篇 |
2020年 | 19篇 |
2019年 | 30篇 |
2018年 | 36篇 |
2017年 | 26篇 |
2016年 | 25篇 |
2015年 | 30篇 |
2014年 | 45篇 |
2013年 | 44篇 |
2012年 | 69篇 |
2011年 | 77篇 |
2010年 | 45篇 |
2009年 | 46篇 |
2008年 | 59篇 |
2007年 | 78篇 |
2006年 | 56篇 |
2005年 | 57篇 |
2004年 | 42篇 |
2003年 | 54篇 |
2002年 | 33篇 |
2001年 | 29篇 |
2000年 | 23篇 |
1999年 | 28篇 |
1998年 | 7篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 3篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 7篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1978年 | 2篇 |
1975年 | 2篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1970年 | 1篇 |
1969年 | 8篇 |
1968年 | 7篇 |
1967年 | 5篇 |
1966年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有1110条查询结果,搜索用时 31 毫秒
31.
32.
Frequencies of allele groups HLA‐A,HLA‐B and HLA‐DRB1 in a population from the northwestern region of São Paulo State,Brazil 下载免费PDF全文
C. M. Ayo A. V. da Silveira Camargo D. H. Xavier M. F. Batista O. A. Carneiro C. C. Brandão de Mattos O. Ricci Jr L. C. de Mattos 《International journal of immunogenetics》2015,42(1):19-25
The aim of this study was to estimate the HLA‐A, HLA‐B and HLA‐DRB1 allele groups frequencies in a population of 1559 volunteer bone marrow donors from the northwestern region of São Paulo State grouped according to ethnicity. An additional objective was to compare the allele frequencies of the current study with data published for other Brazilian populations. The allele groups were characterized by the PCR‐rSSO method using Luminex® technology. Twenty HLA‐A, 32 HLA‐B and 13 HLA‐DRB1 allele groups were identified. The most common allele groups in European descent and mixed African and European descent samples were HLA‐A*02, HLA‐B*35 and HLA‐DRB1*13, while HLA‐A*02, HLA‐B*35 and HLA‐DRB1*11 were more common in African descent samples. The HLA‐A*23, HLA‐A*36, HLA‐B*58 and HLA‐B*81 allele groups were more common in sample from African descent than European descent, and the HLA‐DRB1*08 was more common in mixed African and European descent than in European descent. Allele group frequencies were compared with samples from other Brazilian regions. The HLA‐A*30 and HLA‐A*23 were more common in this study than in the populations of Rio Grande do Sul and Paraná; and the HLA‐A*01, HLA‐B*18, HLA‐B*57 and HLA‐DRB1*11 were more common in this study than in the population of Piauí. The least frequent allele groups were HLA‐A*31, HLA‐B*15, HLA‐B*40 and HLA‐DRB1*08 for the population of Piauí, HLA‐A*01 and HLA‐A*11 for Parana, HLA‐A*02 and ‐A*03 for Rio Grande do Sul and HLA‐DRB1*04 for Paraná, Rio Grande do Sul and Piauí. These data provide an overview on the knowledge on HLA diversity in the population of the northwestern region of São Paulo State and show that the genes of this system are useful to distinguish different ethnic groups. 相似文献
33.
34.
Rodrigues RC Almeida EP Faria AC Macedo AP de Mattos Mda G Ribeiro RF 《Journal of prosthodontic research》2012,56(1):58-64
PurposeThe aim of the present study was to evaluate commercially pure titanium (CP Ti) casting quality when a specific to titanium and a conventional phosphate bonded investments were used under different mold temperatures. For this, the evaluated parameters were surface roughness, bending strength, Vickers microhardness, casting quality by radiographies and microstructure of CP Ti.MethodsWax patterns (28 mm × 3 mm × 1 mm) were invested using two phosphate bonded investments: Rematitan Plus (REM), specific to titanium, and Castorit Super C (CAS), a conventional investment, fired and cooled until reaching two mold temperatures: 430 °C (430) and room temperature (RT). Specimens were cast from CP Ti by plasma. After casting, specimens were radiographically examined and submitted to Vickers microhardness, roughness and bending strength evaluation. Microstructure was analyzed in the center and at the surface of specimen.ResultsQualitative analysis of radiographs showed that specimens which were cast using CAS-RT presented more casting porosities while the specimens which were cast with REM-430 did not present any casting porosity. No significant difference was noted among the groups in the surface roughness and Vickers microhardness data, but the bending strength of the specimens cast using CAS was greater than REM groups. The microstructure of the specimens of the different groups was similar, presenting a feather-like aspect.ConclusionCasting porosities found in the specimens cast using conventional investments (CAS) and lower mold temperatures would limit their use, even mechanical properties were similar than in specimens cast using specific to titanium investment (REM) at temperatures recommended by the manufacturer. 相似文献
35.
Storti-Melo LM da Costa DR Souza-Neiras WC Cassiano GC Couto VS Póvoa MM Soares Ida S de Carvalho LH Arevalo-Herrera M Herrera S Rossit AR Cordeiro JA de Mattos LC Machado RL 《Acta tropica》2012,121(2):152-155
We evaluated the influence of allelic frequency of the human leukocyte antigen (HLA) -DRB1 on the acquisition of antibody response against malaria sporozoite and merozoite peptides in patients with Plasmodium vivax malaria acquired in endemic areas of Brazil. IgG antibodies were detected by enzyme-linked immunosorbent assay against four peptides of circumsporozoite protein (CSP) (amino, carboxyl, and VK210 and VK247 repeats) and peptides of merozoite surface protein 1 (MSP-1), apical membrane antigen 1 (AMA-1), and Duffy-binding protein (DBP). We found an association between HLA-DR3 and HLA-DR5 alleles and lack of antibody response to CSP amino terminal, as well as an association between HLA-DR3 and the highest antibody response to MSP1 (Pv200L). In conclusion, we suggest a potential regulatory role of the HLA-DRB1 alleles in the production of antibodies to a conserved region of P. vivax CSP and MSP1 in Brazilian population exposed to malaria. 相似文献
36.
37.
38.
It is not unusual that patients with systemic lupus erythematosus (SLE) progress to terminal renal failure and subsequently require renal replacement therapy. Previous studies have shown that clinical and/or serological remission in patients with SLE is common in those who develop end-stage renal disease (ESRD). On the other hand, the persistence of lupus activity among patients undergoing long-term dialysis is not rare, either. The aim of this study is to define, by means of a systematic review, the course of SLE activity in patients who developed ESRD. Data were obtained through searches for articles in the MEDLINE (1966 to 2011), SCielo, and LILACS databases, using the following keywords: "chronic renal failure", "systemic lupus erythematosus", "end-stage renal disease", "lupus activity", "disease activity", "lupus flare", "hemodialysis", and "renal replacement therapy" and their corresponding translations in Portuguese. Twenty-four articles were found which evaluated the degree of lupus activity in patients with ESRD. Fifteen of these studies spoke of a substantial reduction of clinical and/or serological activity after the development of ESRD, while nine articles found that the amount of clinical and/or serological activity was similar to that of the phase prior to terminal renal failure, or it occurred in at least 50% of the patients studied. Although the majority of studies showed that lupus flares tend to decrease in frequency in patients who develop ESRD, in this scenario, one should be prepared to correctly diagnose a recurrence of the disease, as well as to perform appropriate therapy. 相似文献
39.
40.
Manuel Mendizabal Sebastián Marciano Luciana dos Santos Schraiber Rodrigo Zapata Rodolfo Quiros Maria Lucia Zanotelli María Marta Rivas Gustavo Kusminsky Roberto Humeres Angelo Alves de Mattos Adrián Gadano Marcelo O. Silva 《Clinical transplantation》2013,27(4):E469-E477
Post‐transplant lymphoproliferative disorder (PTLD) is a major and potentially life‐threatening complication after solid‐organ transplantation. The aim of this study was to describe the disease characteristics, clinical practices, and survival related to PTLD in adult orthotopic liver transplant (OLT) recipients in South America. We conducted a survey at four different transplant groups from Argentina, Brazil, and Chile. Among 1621 OLT recipients, 27 developed PTLD (1.7%); the mean age at diagnosis was 53.7 (±14) yr with a mean time of 39.7 (±35.2) months from OLT to PTLD diagnosis. Initial therapy included reduction in immunosuppression alone in 23.1% of the patients. Either rituximab or chemotherapy was employed as initial or second‐line therapy in 76.9% of the patients. PTLD location was frequently extranodal (80.7%) and mostly involving the transplanted liver (59.3%). The overall survival at one and five yr post‐PTLD diagnosis was 53.8% and 46.2%, respectively. Significant univariate risk factors for post‐PTLD mortality included lactate dehydrogenase ≥250 U/L (HR 9.66, p = 0.02), stage III/IV PTLD (HR 5.34, p = 0.004), and HCV infection (HR 7.68, p = 0.01). In conclusion, PTLD in OLT adult recipients is predominantly extranodal, and although mortality is high, long‐term survival is possible. 相似文献